166 related articles for article (PubMed ID: 37037397)
1. Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment.
Husni P; Lim C; Oh KT
Int J Pharm; 2023 May; 639():122942. PubMed ID: 37037397
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Drug Conjugate for Enhancing Drug Delivery.
Irby D; Du C; Li F
Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
[TBL] [Abstract][Full Text] [Related]
3. Lipid Drug Conjugates for Improved Therapeutic Benefits.
Shrivastava P; Gautam L; Jain A; Vishwakarma N; Vyas S; Vyas SP
Curr Pharm Des; 2020; 26(27):3187-3202. PubMed ID: 32160838
[TBL] [Abstract][Full Text] [Related]
4. Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy.
Joubert N; Denevault-Sabourin C; Bryden F; Viaud-Massuard MC
Eur J Med Chem; 2017 Dec; 142():393-415. PubMed ID: 28911823
[TBL] [Abstract][Full Text] [Related]
5. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-Responsive Prodrug Chemistries for Cancer Therapy.
Bargakshatriya R; Pramanik SK
Chembiochem; 2023 Sep; 24(18):e202300155. PubMed ID: 37341379
[TBL] [Abstract][Full Text] [Related]
8. A Tumor-Specific Cascade-Activating Smart Prodrug System for Enhanced Targeted Therapy.
Wang Q; Jin D; Liu C; Shi L; Li T
Small; 2024 Jun; 20(24):e2309482. PubMed ID: 38150668
[TBL] [Abstract][Full Text] [Related]
9. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
10. In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability.
Ma Y; He H; Xia F; Li Y; Lu Y; Chen D; Qi J; Lu Y; Zhang W; Wu W
Nanomedicine; 2017 Nov; 13(8):2643-2654. PubMed ID: 28778838
[TBL] [Abstract][Full Text] [Related]
11. Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment.
Lu S; Zhang C; Wang J; Zhao L; Li G
Biomed Pharmacother; 2024 Jan; 170():116059. PubMed ID: 38154273
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
13. Bio-Responsive Macromolecular Drug and Small-Molecular Drug Conjugates: Nanoparticulate Prodrugs for Tumor Microenvironment Heterogeneity Management and Therapeutic Response Enhancement.
Li Y; Liang X; Shen C; Deng K; Zeng Z; Guo B; Xu X
Small; 2023 Sep; 19(39):e2301656. PubMed ID: 37144435
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment Stimuli-Responsive Polymeric Prodrug Micelles for Improved Cancer Therapy.
Zhang Z; Yu M; An T; Yang J; Zou M; Zhai Y; Sun W; Cheng G
Pharm Res; 2019 Dec; 37(1):4. PubMed ID: 31823030
[TBL] [Abstract][Full Text] [Related]
15. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
16. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery.
Takalani F; Kumar P; Kondiah PPD; Choonara YE; Pillay V
Pharm Dev Technol; 2020 Mar; 25(3):267-280. PubMed ID: 31744408
[TBL] [Abstract][Full Text] [Related]
17. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect.
Luo Q; Lin L; Huang Q; Duan Z; Gu L; Zhang H; Gu Z; Gong Q; Luo K
Acta Biomater; 2022 Apr; 143():320-332. PubMed ID: 35235863
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-responsive hydrogels for intratumoral drug delivery.
Marques AC; Costa PJ; Velho S; Amaral MH
Drug Discov Today; 2021 Oct; 26(10):2397-2405. PubMed ID: 33892147
[TBL] [Abstract][Full Text] [Related]
19. Nano lipid-drug conjugate: An integrated review.
Adhikari P; Pal P; Das AK; Ray S; Bhattacharjee A; Mazumder B
Int J Pharm; 2017 Aug; 529(1-2):629-641. PubMed ID: 28723407
[TBL] [Abstract][Full Text] [Related]
20. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
